Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors
Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors
Enrolling by invitation · NCT06211413 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors | Arrhythmias, Cardiac, B-cell chronic lymphocytic leukemia, Cardiotoxicity, Chemically-Induced Disorders, Chronic Disease, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, hematologic disorder, hypertensive disorder, immune system disorder, immunoproliferative disorder, injury, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, radiation injury, vascular disorder | Enrolling by invitation | Not stated | 2026-10-05 | NCT06211413 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 137 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center at University of Pennsylvania | Philadelphia | United States | 11 |